Acetylsalicylic acid Recruiting Phase 4 Trials for Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03431142Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial